A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
Mayo researchers recommend all women with breast cancer diagnosis under age 66
- EurekAlert
- 2. 3 2020 (06:00)